ACQUISITION OF BENEFICIAL OWNERSHIP

Company

Aptevo Therapeutics Inc.

Filed

March 11, 2020

Accession Number

0001387131-20-002761

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →